Both FLT-1 and KDR are expressed on lung cancer cells, and previous experiments have confirmed that VEGF can stimulate KDR expression; moreover, only the KDR expression by tumor cells is consistent with VEGF expression, which is consistent with the results of this study and suggests that angiogenesis may be primarily mediated by KDR. The gene discussed is FLT1; the disease is lung carcinoma.